Fleeing the nursery, Elias Thorne’s cold façade snapped back into place. Any lingering hint of vulnerability vanished like smoke. He strode down the silent hallway, the ghost of a tear now completely erased. Morning light streamed into his penthouse office, but Elias felt no warmth. His fingers flew across the keyboard, reviewing market projections, acquisition proposals, and the intricate web of Thorne Industries. Routine, brutal efficiency. His personal life was meticulously compartmentalized. Hours later, a digital alert flickered on his secondary monitor. A minor anomaly in the data stream from 'Project Nightingale,' Thorne BioSolutions’ cutting-edge gene therapy initiative. This project held the key to Lily's rare genetic condition. Dismissing it initially as a system glitch, Elias swiped it away. His focus remained on a multi-billion dollar merger. He had no time for minor disruptions, not when the stakes were so high for the company's expansion. Moments later, another alert. Then another, more insistent. These weren't random system hiccups. The notifications, usually green, now pulsed an alarming, persistent amber. "Mr. Thorne?" Dr. Aris Thorne, Elias’s cousin and the lead scientist for Project Nightingale, appeared at his office door. His brow was deeply furrowed, a rare sight for the usually calm, methodical geneticist. "Aris," Elias acknowledged, his gaze still fixed on the screen, though his attention was now split. "Problem?" "A series of corrupted data packets," Aris explained, stepping closer, his voice tight. "Originating from within the Nightingale servers. It’s critically affecting the live experimental simulations." Elias finally looked up, his eyes narrowing to dangerous slits. "Corrupted how? Be specific." "Subtle, at first. Almost imperceptible," Aris elaborated, his hands gesturing precisely. "Shifting a single nucleotide base pair in a complex gene sequence, altering a statistical probability in a drug interaction model. It almost perfectly mimics random experimental variance or human error." "But it's not random," Elias finished, his voice a low growl. He knew Aris well enough to read the unspoken urgency. "Exactly," Aris confirmed, his jaw clenching. "It's too specific. Too consistent in its *inconsistency*. Targeting specific parameters that would lead to false negatives for promising therapeutic candidates." Instantly, Elias’s mind shifted into high alert. Random variance didn’t selectively target critical genetic pathways. It didn’t subtly undermine the viability of specific, promising gene constructs. This was surgical. Devastatingly precise. "Get your entire team on it," Elias commanded, his voice now devoid of any warmth. "Quarantine the affected data immediately. Trace the source. I want a full, unvarnished report by end of day, no matter what." Aris nodded sharply, already pulling out his tablet, his fingers flying across the screen. "We're already isolating what we can. But it's widespread, Elias. Spanning multiple, seemingly unrelated experimental batches, like a slow-acting poison." Watching his cousin stride out, Elias felt a cold prickle of dread. Sabotage. The word hung unspoken, heavy in the sterile air of his opulent office. Who would dare attempt something so sophisticated, so insidious? And why target Nightingale, a project dedicated to groundbreaking medical solutions? His mind raced through a mental database of competitors, disgruntled former employees, shadowy business rivals. But none possessed the technical sophistication for this level of internal infiltration. Or the callous motive to target such a sensitive, humanitarian-focused medical project. Days blurred into a tense, grinding cycle of updates and frustrating dead ends. The Thorne Industries IT security team, renowned as the best in the world, worked relentlessly, round the clock. They found no external breach. No firewall penetration. No brute-force attack. Frustratingly, the corruption originated *inside* the secure system. Like a ghost in the machine, it moved silently, meticulously altering data points, invalidating promising research lines, making genuinely viable solutions appear flawed or ineffective. Lily’s fragile face flashed in Elias’s mind. Every single delay in Project Nightingale was a direct delay in her potential treatment, in her chance at a normal life. This wasn't just a corporate attack; it was deeply, agonizingly personal. Dr. Aris Thorne, his face etched with profound exhaustion, his usually neat hair now disheveled, appeared again in Elias’s office. It was well past midnight. The city lights twinkled like cold, distant stars far below. "We found it," Aris stated, his voice flat, devoid of any triumph. He slammed a thick, ring-bound file onto Elias’s polished desk. The thud echoed in the silent room. Flipping it open, Elias scanned the detailed report. His eyes absorbed the technical jargon, the diagrams, the alarming flowcharts. Anomalous code fragments. Deliberately obfuscated and encrypted. Injected deep into the core of the Nightingale database, designed to activate at specific, strategic intervals, targeting specific, critical data sets. "It wasn't a hack in the conventional sense," Aris continued, running a weary hand through his hair. "It was an internal injection. A sophisticated, self-propagating worm designed to rot the project from the inside out, piece by insidious piece." Elias’s jaw tightened, a hard muscle twitching near his temple. His knuckles turned white as he gripped the edge of the desk. "Who implemented this? Who wrote it?" "That's the terrifying part, Elias," Aris whispered, his eyes wide with a chilling realization. "The code is utterly untraceable. Expertly masked. It mimics the coding style of several of our own most senior internal developers, making attribution practically impossible." This wasn’t a clumsy, opportunistic attempt. This was professional. Highly skilled. Highly funded. Someone knew the Nightingale system intimately, knew its vulnerabilities, and its critical pathways. "Every promising lead, every breakthrough we've painstakingly made in the last two months, has been subtly, systematically undermined," Aris reported, his voice tinged with a profound despair. "False positives, corrupted control groups, altered efficacy rates, deliberately skewed results. It's a systemic unraveling of everything we've built." He pointed a trembling finger to a specific, highlighted section in the voluminous report. "This particular sequence of code… it directly targeted the viability markers for the specific gene therapy we were developing for rare mitochondrial disorders. Lily's exact condition." Elias felt a cold, crushing dread settle deep in his stomach, twisting his gut. This wasn't just a vicious corporate hit. This was a targeted, malicious attack on his daughter's life, on her only hope for a future. "The integrity of all our recent data is irrevocably compromised," Aris said, his voice dropping to a grave, almost inaudible whisper. "We're essentially back to square one on several key fronts, potentially losing months, maybe even a year, of critical research time." His gaze, heavy with warning, met Elias's. It held a chilling certainty. "Someone is deliberately trying to ruin everything, Mr. Thorne."

Chapter 21: A Calculated Sabotage